Advances in targeted alpha therapy of cancer

Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1205-1206. doi: 10.1007/s00259-024-06658-1.

Authors

Mike Sathekge¹, Alfred Morgenstern²

Affiliations

¹ Steve Biko Academic Hospital, Nuclear Medicine Research Infrastructure (NuMeRI), University of Pretoria, Pretoria, South Africa. mike.sathekge@up.ac.za.
² European Commission, Joint Research Centre, Karlsruhe, Germany.

PMID: 38376807
DOI: 10.1007/s00259-024-06658-1

No abstract available

Publication types

Editorial

MeSH terms

Humans
Molecular Targeted Therapy
Neoplasms* / radiotherapy